D
Danielle Denis
Researcher at Merck & Co.
Publications - 47
Citations - 2556
Danielle Denis is an academic researcher from Merck & Co.. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 25, co-authored 47 publications receiving 2447 citations.
Papers
More filters
Journal ArticleDOI
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.
Mark Abramovitz,Mohammed Adam,Yves Boie,Marie-Claude Carrière,Danielle Denis,Claude Godbout,Sonia Lamontagne,C. Rochette,Nicole Sawyer,Nathalie Tremblay,Michel Belley,Michel Gallant,Claude Dufresne,Yves Gareau,Rejean Ruel,Helene Juteau,Marc Labelle,Nathalie Ouimet,Kathleen M. Metters +18 more
TL;DR: Rec recombinant cell lines have been employed in radioligand binding assays to determine the equilibrium inhibitor constants of known prostanoid receptor ligands at these eight receptors, allowing, for the first time, an assessment of the affinity and selectivity of several novel compounds at the individual human prostate receptors.
Journal ArticleDOI
Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation.
François Nantel,Danielle Denis,Robert Gordon,Angela Northey,Maria Cirino,Kathleen M. Metters,Chi-Chung Chan +6 more
TL;DR: It is suggested that multiple mechanisms regulate COX‐2 induction especially in the more severe model of acute inflammation, carrageenan‐induced paw ædema and mechanical hyperalgesia, which suggest the presence of a positive feedback loop mechanism.
Journal ArticleDOI
Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly
TL;DR: To gain insight into the role of prostanoids in human kidney function, the distribution of cyclooxygenase (COX) 1 and COX‐2 by immunofluorescence and immunohistochemistry in human kidneys from adults of various age groups is examined.
Journal ArticleDOI
Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor.
Helene Juteau,Yves Gareau,Marc Labelle,Claudio Sturino,Nicole Sawyer,Nathalie Tremblay,Sonia Lamontagne,Marie-Claude Carrière,Danielle Denis,Kathleen M. Metters +9 more
TL;DR: The structure-activity relationship of the chemical series was conducted and several analogues displaying sub-nanomolar K(i) values at the EP3 receptor and micromolar activities at theEP1, EP2 and EP4 receptors were found.
Journal ArticleDOI
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
W. C. Black,C. Bayly,M. Belley,Chi-Chung Chan,Stella Charleson,Danielle Denis,Jacques-Yves Gauthier,R. Gordon,Daniel Guay,Stacia Kargman,Lau Cheuk-Kun,Yves Leblanc,Joseph A. Mancini,Marc Ouellet,David Percival,Patrick Roy,Kathryn Skorey,Philip Tagari,Philip J. Vickers,E. Wong,Lijing Xu,Petpiboon Prasit +21 more
TL;DR: A series of potent and highly selective cyclooxygenase-2 inhibitors have been prepared by replacing the benzoyl group of indomethacin with a 4-bromobenzyl group and by extending the acetic acid side chain, showing anti-inflammatory activity in rats with no evidence of GI toxicity, even at high doses.